Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 18/20 | 0.53 |
| ▸ | CDK2AP1 | O14519 | 3/20 | 0.52 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.51 |
| ▸ | IKBKB | O14920 | 1/20 | 0.49 |
| ▸ | JAK2 | O60674 | 1/20 | 0.49 |
| ▸ | JAK3 | P52333 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1563507 | 0.82 | CHEK1 (0.52) | CHEK1CDK2AP1MAP4K4IKBKBJAK2 | |
| SCHEMBL1563258 | 0.82 | CHEK1 (0.53) | CHEK1CDK2AP1MAP4K4IKBKBJAK2 | |
| SCHEMBL7053485 | 0.81 | JAK2 (0.73) | CHEK1MAP4K4IKBKBJAK2JAK3 | |
| SCHEMBL1563808 | 0.79 | CHEK1 (0.51) | CHEK1CDK2AP1MAP4K4IKBKB | |
| SCHEMBL1563080 | 0.77 | CHEK1 (0.79) | CHEK1CDK2AP1 | |
| SCHEMBL1564867 | 0.76 | CHEK1 (0.86) | CHEK1CDK2AP1 | |
| SCHEMBL5007464 | 0.76 | CHEK1 (0.67) | CHEK1CDK2AP1MAP4K4 | |
| SCHEMBL1564842 | 0.76 | CHEK1 (0.82) | CHEK1CDK2AP1 | |
| SCHEMBL5007252 | 0.74 | CHEK1 (0.46) | CHEK1MAP4K4IKBKBJAK2JAK3 | |
| SCHEMBL5898639 | 0.73 | JAK2 (0.65) | CHEK1IKBKBJAK2JAK3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2305671-A1 | Thiophene and thiazole derivatives as CHK1 inhibitors | AstraZeneca AB (SE) | 2011-04-06 | — | — | EP | disclosed |